BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 1122 | Download: 822
Publication Name World Journal of Gastroenterology
Manuscript ID 5876
Country Switzerland
Received
2013-09-28 17:56
Peer-Review Started
2013-09-29 14:55
To Make the First Decision
2013-11-21 20:58
Return for Revision
2013-11-22 09:46
Revised
2013-12-13 14:56
Second Decision
2014-02-20 15:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-02-20 16:01
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-05 09:25
Publish the Manuscript Online
2014-05-18 12:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Topic Highlights
Article Title Immune responses to Helicobacter pylori infection
Manuscript Source Invited Manuscript
All Author List Mati Moyat and Dominique Velin
Funding Agency and Grant Number
Funding Agency Grant Number
Swiss National Foundation 310030_141145 (to Velin D)
Corresponding Author Dominique Velin, PhD, Service of Gastroenterology and Hepatology, Department of Medicine, Lausanne University Hospital, BH18-521, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland. dominique.velin@chuv.ch
Key Words Helicobacter pylori; Vaccine; Immune response; Peptic ulcer; Gastric cancer
Core Tip Helicobacter pylori (H. pylori) infection is one of the most common infections in human beings worldwide. H. pylori actively induce tolerogenic signals and can be considered as a commensal bacteria belonging to the stomach microbiota. However, H. pylori also promote a chronic inflammation in the gastric mucosa and the direct action of virulence factors confers pro-carcinogenic activities to H. pylori. Hence, H. pylori cannot be considered as symbiotic bacteria but rather as part of the pathobiont. The development of a H. pylori vaccine will bring health benefits for individuals infected with antibiotic resistant H. pylori strains and population of underdeveloped countries.
Publish Date 2014-05-18 12:31
Citation Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol 2014; 20(19): 5583-5593
URL http://www.wjgnet.com/1007-9327/full/v20/i19/5583.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i19.5583
Full Article (PDF) WJG-20-5583.pdf
Full Article (Word) WJG-20-5583.doc
Manuscript File 5876-Review.docx
Answering Reviewers 5876-Answering reviewers.pdf
Copyright License Agreement 5876-Copyright assignment.pdf
Peer-review Report 5876-Peer reviews.pdf
Scientific Editor Work List 5876-Scientific editor work list.doc